Выпуск
Pharmaceutical Executive Daily: Peptide Ruling Stalls
Pharmaceutical Executive · 30 сентября 2026 г. · 2 мин
Novo Nordisk data show real-world weight loss after switching to its oral semaglutide pill, FDA's peptide rulemaking stalls while its enforcement arm targets compounded peptide sellers, and Avi Pardo flags a compliance blind spot in field teams' text messages with doctors.